Most patients stop using Wegovy, Ozempic for weight loss within two years

Only one in four U.S. patients prescribed Novo Nordisk’s (NOVOb.CO) Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of U.S. pharmacy claims provided to Reuters that also showed a steady decline in use over time.